Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Etomidate Injection
Status: Currently in Shortage
»Date first posted:
10/05/2022
»Therapeutic Categories: Anesthesia
Caplin Steriles, Ltd. (Reverified 04/08/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 2 mg/1 mL (NDC 65219-445-10) | Available | Check wholesalers for inventory; Marketed by Fresenius Kabi
Fresenius Kabi Etomidate Shelf Life Extension Letter Search List of Extended Use Dates to Assist with Drug Shortages |
|
| Injection, 40 mg/20 mL (NDC 65219-445-20) | Available | Check wholesalers for inventory; Marketed by Fresenius Kabi
Fresenius Kabi Etomidate Shelf Life Extension Letter Search List of Extended Use Dates to Assist with Drug Shortages |
|
| Injection, 2 mg/1 mL (NDC 25021-674-10) | Available | Marketed by Sagent | |
| Injection, 2 mg/1 mL (NDC 25021-674-20) | Available | Marketed by Sagent |
Eugia US LLC (Revised 04/16/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 20 mg/10 mL (NDC 55150-221-10) | Available | Check wholesalers for inventory | |
| Injection, 40 mg/20 mL (NDC 55150-222-20) | Available | Check wholesalers for inventory |
Gland Pharma Limited (Reverified 03/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10) | Available | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | |
| Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10) | Available | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. |
Hikma Pharmaceuticals USA, Inc. (Revised 04/16/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 2 mg/1 mL (NDC 0143-9506-10) | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| Injection, 2 mg/1 mL (NDC 0143-9507-10) | Available | Additional lots will be available. Product will be made available as it is released. | |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) | Pending information | ||
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) | Pending information | ||
| Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10) | Pending information | Distributed by Civica | |
| Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10) | Pending information | Distributed by Civica |
Hospira, Inc., a Pfizer Company (Revised 03/28/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) | Available | ||
| Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-02) | Available |
Mylan Institutional, a Viatris Company (Reverified 04/16/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10) | Available | ||
| Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20) | Available |